188
86.
PereiraH,CruzM,AlmeidaM,QuadradoMJ,Murta JN.Microscopiaconfocalnaavaliaçãode falência
do limbo dador após transplante autólogo de limbo e conjuntiva no tratamento de pterigium.
Oftalmologia2011;3:259-268.
87.
Miri A, Said DG, Dua HS. Donor site complications in autolimbal and living-related allolimbal
transplantation.Ophthalmology2011;118:1265-1271.
88.
UyHS, Reyes JMG, Flores JDG, Lim-Bon-SiongR. Comparisonof fibrin glueand sutures for attaching
conjunctival autograftsafterpterygiumsurgery.Ophthalmology2005;112:667-671.
89.
PanH,ZhangJ,JingC.Comparisonoffibringlueversussutureforconjunctivalautografting inpterygium
surgery:ameta-analysis.Ophthalmology2011;118:1049-1054.
90.
SrinivasanS, DollinM,McAllumP, Berger Y, RootmanDS; SlomovicAR. Fibringlue versus sutures for
attaching theconjunctivalautograft inpterygiumsurgery:aprospectiveobservermaskedclinical trial.
Br JOphthalmol 2009;93:215-218.
91.
FossarelloM,PeirettiE,ZuccaI,PerraMT,SerraA.Photodinamictherapyofpterygiumwithverteporfin.
Apreliminary report.Cornea2004;23:330-338.
92.
Hueber A, Grisanti S, Diestelhorst M. Photodynamic therapy for wound-healing modulation in
pterygiumsurgery.Aclinicalpilot study.GraefesArchClinExpOphthalmol 2005;243:942-946.
93.
Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygiummorphology on pterygium recurrence in a
controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol.
1997;115:1235-1240.
94.
Ti SE, Tseng SC. Management of primary and recurrent pterygium using amniotic membrane
transplantation.CurrOpinOphthalmol 2002;13:204-212.
95.
KheirkhahA,HashemiH,AdelpourM,NikdelM,RajabiMB,BehrouzMJ.Randomizedtrialofpterygium
surgerywithmitomycinCapplicationusingconjunctivalautograftversusconjunctival-limbalautograft.
Ophthalmology.2012;119:227-232.
96.
AltiparmakUE, KatircioğluYA, Yağci R, Yalniz Z, DumanS.MitomycinCand conjunctival autograft for
recurrentpterygium. IntOphthalmol.2007;27:339-343.
97.
Shehadeh-Mashor R, Srinivasan S, Boimer C, Lee K, Tomkins O, Slomovic AR. Management of
recurrentpterygiumwith intraoperativemitomycinCandconjunctivalautograftwithfibringlue.Am J
Ophthalmol.2011;152:730-732.
98.
BekibeleCO, AshayeA,OlusanyaB, BaiyerojuA, FasinaO, IbrahimAO,OgunO. 5-Fluorouracil versus
mitomycinCasadjunctstoconjunctivalautograft inpreventingpterygiumrecurrence. IntOphthalmol
2012;32:3-8.
99.
Shimazaki J, KosakaK, ShimmuraS, TsubotaK.Amnioticmembrane transplantationwithconjunctival
autograft for recurrentpterygium.Ophthalmology2003;110:119-124.
100.
YoungAL, TamPM, LeungGY, ChengLL, LamPT, LamDS. Prospective studyon the safetyandefficacy
of combined conjunctival rotational autograft with intraoperative 0.02%mitomycin C in primary
pterygiumexcision.Cornea2009;28:166-169.
101.
NabawiKS,GhonimMA,AliMH.Evaluationof limbalconjunctivalautograftand low-dosemitomycinC
in the treatmentof recurrentpterygium.OphthalmicSurgLasers Imaging2003;34:193-196.
102.
FallahMR,BolabdarMR,AmozadehJ,ZareMA,MoghimiS,FakhraeeG.Transplantationofconjunctival
limbal autograft and amnioticmembrane vsmitomycin C and amnioticmembrane in treatment of
recurrentpterygium. Eye (Lond)2008;22:420-424.
103.
YaoY-F,QiuW-Y, ZhangY-W, TsengSCG.MitomycinC, amnioticmembrane transplantationand limbal
conjunctivalautograft fortreatingmultirecurrentpterygiawithsymblepharonandmotilityrestriction.
Graefe’sArchClinExpOphthalmol 2006;244:232-236.
